Carcinoma of the Oesophagus Clinical Trial
Official title:
Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus. A Phase I Trial.
The purpose of this study is to determine the Maximum Tolerated Dose (MTD) of olaparib in combination with radical radiotherapy in patients with oesophageal cancer who are unsuitable for platinum containing chemotherapy.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment